Composition and method for inducing apoptosis in prostate cancer cells
CA 2366090 C · Owner: Bioniche Inc. · Inventors: Phillips, Nigel C.; Filion, Mario C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for treating prostate cancer in an animal wherein a composition , comprising Mycobacterium phlei (M. phlei) DNA (M-DNA) and M-DNA preserved and complexed on M. phlei cell wall (MCC) is administered to the animal in need of such treatment in an amount effective to have an anti-neoplastic effect on cancer cells in the prostate of the animal.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 30, 2000 and granted May 24, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 30, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 30, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.